NFKB1 and metabolic dysfunction-associated steatotic liver disease: Collectively, our findings demonstrated that circRNA_0001805 inhibited NF-κB signaling cascades and promoted ABCA1/CPT1 expression in mice; these results corroborated the protective role of circRNA_0001805 against NAFLD-induced lipid metabolism disorder and hepatic inflammation in vivo.